These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Aberrant methylation and expression of DAPk1 in human hypopharyngeal squamous cell carcinoma. Wei DM, Liu DY, Lei DP, Jin T, Wang J, Pan XL. Acta Otolaryngol; 2015 Jan; 135(1):70-8. PubMed ID: 25496179 [Abstract] [Full Text] [Related]
7. Overexpression of S100A4 Predicts Migration, Invasion, and Poor Prognosis of Hypopharyngeal Squamous Cell Carcinoma. Xu J, Gross N, Zang Y, Cao S, Yang F, Yang Z, Yu W, Lei D, Pan X. Mol Diagn Ther; 2019 Jun; 23(3):407-417. PubMed ID: 30868407 [Abstract] [Full Text] [Related]
8. Hypermethylation of the G protein-coupled receptor kinase 6 (GRK6) promoter inhibits binding of C/EBPα, and GRK6 knockdown promotes cell migration and invasion in lung adenocarcinoma cells. Yao S, Wu D, Chen J, Wang P, Lv X, Huang J. FEBS Open Bio; 2019 Apr; 9(4):605-617. PubMed ID: 30984536 [Abstract] [Full Text] [Related]
13. Spatial transcriptomics reveal tumor microenvironment and SLCO2A1 correlated with tumor suppression in hypopharyngeal squamous cell carcinoma. Li C, Xu C, Guan R, Jiao R, Wang Y, Cui C, Cao S, Chang F, Wei R, Li Z, Liu Z, Gross ND, Li G, Li W, Wei D, Lei D. Int Immunopharmacol; 2024 Dec 05; 142(Pt B):113243. PubMed ID: 39340989 [Abstract] [Full Text] [Related]
14. CDCA3 promotes the proliferation and migration of hypopharyngeal squamous cell carcinoma cells by activating the Akt/mTOR pathway. Wu J, Cui M, Wang J, Fan J, Liu S, Lou W. Biotechnol Genet Eng Rev; 2024 Oct 05; 40(2):707-725. PubMed ID: 36892980 [Abstract] [Full Text] [Related]
15. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours. Veeck J, Bektas N, Hartmann A, Kristiansen G, Heindrichs U, Knüchel R, Dahl E. Breast Cancer Res; 2008 Oct 05; 10(5):R82. PubMed ID: 18826564 [Abstract] [Full Text] [Related]
16. Aberrant promoter hypermethylation of the CHFR gene in oral squamous cell carcinomas. Baba S, Hara A, Kato K, Long NK, Hatano Y, Kimura M, Okano Y, Yamada Y, Shibata T. Oncol Rep; 2009 Nov 05; 22(5):1173-9. PubMed ID: 19787237 [Abstract] [Full Text] [Related]
17. TMEM16A inhibits autophagy and promotes the invasion of hypopharyngeal squamous cell carcinoma through mTOR pathway. Yang X, Cui L, Liu Z, Li Y, Wu X, Tian R, Jia C, Ren C, Mou Y, Song X. Carcinogenesis; 2024 Aug 12; 45(8):569-581. PubMed ID: 38470063 [Abstract] [Full Text] [Related]
18. Aberrant hypermethylation and reduced expression of disabled-2 promote the development of lung cancers. Xie XM, Zhang ZY, Yang LH, Yang DL, Tang N, Zhao HY, Xu HT, Li QC, Wang EH. Int J Oncol; 2013 Nov 12; 43(5):1636-42. PubMed ID: 24002585 [Abstract] [Full Text] [Related]
19. miR-107 Targets NSG1 to Regulate Hypopharyngeal Squamous Cell Carcinoma Progression through ERK Pathway. Hu Y, He Z, Han B, Lin Z, Zhou P, Li S, Huang S, Chen X. Int J Mol Sci; 2024 May 29; 25(11):. PubMed ID: 38892156 [Abstract] [Full Text] [Related]
20. Hypermethylation-modulated down-regulation of CDH1 expression contributes to the progression of esophageal cancer. Ling ZQ, Li P, Ge MH, Zhao X, Hu FJ, Fang XH, Dong ZM, Mao WM. Int J Mol Med; 2011 May 29; 27(5):625-35. PubMed ID: 21373750 [Abstract] [Full Text] [Related] Page: [Next] [New Search]